Gross Margin

Aditxt's $36M acquisition of Ignite Proteomics aims to upend cancer therapy by analyzing protein activity, a high-stakes bet for the struggling innovator.

The German biotech firm secured its Nasdaq listing, but a near-total investor redemption leaves its cancer-drug pipeline with less than $1M in trust funds.

Crane NXT adds Benchmark Electronics CEO Jeffrey Benck to its board, signaling a strategic pivot towards deeper tech expertise as a veteran director departs.

The organic kids' food brand reports impressive sales and a strong IPO, but investors are keenly watching its strategy for long-term profitability.

Hydrafacial's parent company posts a massive jump in profitability for 2025, but slowing device sales and cautious guidance raise questions for 2026.

After a tough 2025, the gaming giant touts record margins and an aggressive 2026 plan, betting on new gear and a massive market catalyst for growth.

As FGI Industries prepares its 2025 results, investors watch for clues on the health of the home improvement sector amid economic uncertainty.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

A new report reveals a massive care gap for 76 million US cats, offering a $34 billion roadmap for vets to boost revenue and improve feline health.

New research shows a telehealth model boosting GLP-1 results to over 26% weight loss, but its reliance on unapproved compounded drugs raises safety flags.

A global industrial giant's 10-14% surcharge reveals the direct line from Mideast conflict to higher costs for your local hospital and restaurant.

The precision oncology firm reports a dramatic cut in net loss and a strategic pivot paying off, bolstered by a new U.S. patent for its cancer tech.

Blackline Safety posts record Q1 revenue, fueled by its booming recurring service model and new connected safety tech, despite a dip in US product sales.

The discount giant posts a 106% jump in quarterly profit and outlines aggressive store renovation and expansion plans for 2026 after a stellar year.

Ballard Power Systems reports a landmark 2025 with 43% revenue growth, a 37-point margin jump, and its best quarterly cash flow in a decade.

With its earnings call set for March 26, Designer Brands faces a crucial moment. Can its new strategies overcome a tough market and deliver on growth?

The brokerage giant reports a 108% surge in annual net income, topping 3.3 million funded accounts and signaling major investments in tech innovation.

Industry pioneer Lee Leichter joins EdgeOne Medical, a strategic move to master the complex, high-stakes world of combination product regulation.

Psyence BioMed is building a pharmaceutical powerhouse by controlling its supply chain, a strategic move that could redefine the future of psychedelic medicine.

A new report shows Munich and Hamburg are outpacing rivals in attracting investment, leveraging online credibility as a powerful new tool on the global stage.